Hasil Pencarian - Samuel Litwin

  • Menampilkan 1 - 10 hasil dari 10
Perbaiki Hasil
  1. 1
    Hepatitis B Virus DNA Integration and Clonal Expansion of Hepatocytes in the Chronically Infected Liver

    Hepatitis B Virus DNA Integration and Clonal Expansion of Hepatocytes in the Chronically Infected Liver oleh William S. Mason, Allison R. Jilbert, Samuel Litwin

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Mechanism for CCC DNA synthesis in hepadnaviruses.

    Mechanism for CCC DNA synthesis in hepadnaviruses. oleh Ji A Sohn, Samuel Litwin, Christoph Seeger

    Diterbitkan 2009-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Immune Tolerant Chronic Hepatitis B: The Unrecognized Risks

    Immune Tolerant Chronic Hepatitis B: The Unrecognized Risks oleh Patrick T. F. Kennedy, Samuel Litwin, Grace E. Dolman, Antonio Bertoletti, William S. Mason

    Diterbitkan 2017-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Proprotein Convertase Inhibition Results in Decreased Ski Proliferation, Tumorigenesis, and Metastasis

    Proprotein Convertase Inhibition Results in Decreased Ski Proliferation, Tumorigenesis, and Metastasis oleh Daniel E. Bassi, Jirong Zhang, Jonathan Cenna, Samuel Litwin, Edna Cukierman, Andres J.P. Klein-Szanto

    Diterbitkan 2010-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Induction of ovarian leiomyosarcomas in mice by conditional inactivation of Brca1 and p53.

    Induction of ovarian leiomyosarcomas in mice by conditional inactivation of Brca1 and p53. oleh Bridget A Quinn, Tiffany Brake, Xiang Hua, Kimberly Baxter-Jones, Samuel Litwin, Lora Hedrick Ellenson, Denise C Connolly

    Diterbitkan 2009-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Combining anti-ERBB3 antibodies specific for domain I and domain III enhances the anti-tumor activity over the individual monoclonal antibodies.

    Combining anti-ERBB3 antibodies specific for domain I and domain III enhances the anti-tumor activity over the individual monoclonal antibodies. oleh Jimson W D'Souza, Smitha Reddy, Lisa E Goldsmith, Irina Shchaveleva, James D Marks, Samuel Litwin, Matthew K Robinson

    Diterbitkan 2014-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Source, co-occurrence, and prognostic value of PTEN mutations or loss in colorectal cancer

    Source, co-occurrence, and prognostic value of PTEN mutations or loss in colorectal cancer oleh Ilya G. Serebriiskii, Valerii A. Pavlov, Grigorii V. Andrianov, Samuel Litwin, Stanley Basickes, Justin Y. Newberg, Garrett M. Frampton, Joshua E. Meyer, Erica A. Golemis

    Diterbitkan 2023-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    NK cell dysfunction in chronic lymphocytic leukemia is associated with loss of the mature cells expressing inhibitory killer cell Ig-like receptors

    NK cell dysfunction in chronic lymphocytic leukemia is associated with loss of the mature cells expressing inhibitory killer cell Ig-like receptors oleh Alexander W. MacFarlane, Mowafaq Jillab, Mitchell R. Smith, R. Katherine Alpaugh, Marion E. Cole, Samuel Litwin, Michael M. Millenson, Tahseen Al-Saleem, Adam D. Cohen, Kerry S. Campbell

    Diterbitkan 2017-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Increased Expression of the Pro-Protein Convertase Furin Predicts Decreased Survival in Ovarian Cancer

    Increased Expression of the Pro-Protein Convertase Furin Predicts Decreased Survival in Ovarian Cancer oleh Robert E. Page, Andrés J. P. Klein-Szanto, Samuel Litwin, Emmanuelle Nicolas, Raid Al-Jumaily, Peter Alexander, Andrew K. Godwin, Eric A. Ross, Russell J. Schilder, Daniel E. Bassi

    Diterbitkan 2007-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Identification of Wee1 as a target in combination with avapritinib for gastrointestinal stromal tumor treatment

    Identification of Wee1 as a target in combination with avapritinib for gastrointestinal stromal tumor treatment oleh Shuai Ye, Dinara Sharipova, Marya Kozinova, Lilli Klug, Jimson D’Souza, Martin G. Belinsky, Katherine J. Johnson, Margret B. Einarson, Karthik Devarajan, Yan Zhou, Samuel Litwin, Michael C. Heinrich, Ronald DeMatteo, Margaret von Mehren, James S. Duncan, Lori Rink

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: